Diamines & Chemicals Ltd Q2 FY26 – When Ethylene Meets Chaos: Negative Margins, NSE Glamour, and Dahej Drama

1. At a Glance

Once upon a time in Baroda’s industrial corridors, Diamines & Chemicals Ltd (DCL) was a chemical prince charming — India’s only maker of ethylene amines. Fast-forward to Q2 FY26, and our prince seems to have overdosed on its own Piperazine fumes. The stock is now trading at ₹269 — nearly 50% down from its 52-week high of ₹566 — as if investors collectively shouted, “Bas karo bhai!”

With a market cap of ₹262 crore, a stock P/E that doesn’t exist (because the company is loss-making), and a ROCE of just 3.33%, DCL’s results are screaming “chemical hangover.” Revenue crashed to ₹9.30 crore, down 51.5% YoY, while net profit fell deep into red with a loss of ₹4.15 crore, a mind-numbing -269% YoY collapse. The Operating Profit Margin now stands at an equally depressing -8.12%.

To be fair, this is the same company that boasts ISO 9001:2015 and DSIR certifications, runs India’s only ethylene amine plant, and even set up a new specialty chemicals unit through its subsidiary DACL Fine Chem. But for now, investors are more interested in when the bleeding will stop than in which molecule they’re making.

So, buckle up — we’re about to dive into a deep pool of acids, bases, and bad quarters.

2. Introduction

Diamines & Chemicals Ltd (DCL) has been around since 1976, long enough to have seen industrial booms, oil crises, and even the time when Bell Bottom jeans were still fashionable. Yet, here it stands — India’s lone warrior in the ethylene amines space, producing compounds essential for pharmaceuticals, paints, adhesives, lubricants, and water treatment chemicals.

But FY26 hasn’t been kind. In a world where specialty chemical players like Vinati Organics and Deepak Nitrite are boasting ROCEs in the 15–25% range, DCL’s 3.33% looks like an intern’s appraisal letter. And that’s not all — net profit margins have gone from 21.8% in FY24 to -8.12% TTM, turning their “amine empire” into a chemical catastrophe.

Sure, the company got its NSE listing approval in May 2023 and even launched a new specialty chemicals facility at Dahej via DACL Fine Chem Ltd in March 2024. But the financials suggest it may take more than a new plant and a fancy ISO certificate to fix the chemistry here.

As we dig in, the numbers get murkier, the margins thinner, and the jokes… sharper.

3. Business Model – WTF Do They Even Do?

DCL manufactures ethylene amines — a class of organic compounds used in pharma, water treatment, textiles, paints, insecticides, and even lube oil additives. In plain English, if you’re holding a paintbrush, using medicine, or cleaning water, chances are something from DCL’s factory had a role in it.

Its product lineup sounds like a chemistry student’s nightmare — Ethylenediamine (EDA), Diethylenetriamine (DETA), Piperazine Anhydrous, Polyamine mix, and Monoethanolamine. These are sold primarily to industries making quinolones, antihistamines, fungicides, resins, and other everyday invisible heroes of modern life.

In FY23, about 97% of its revenue came from manufactured goods, while 3% came from interest income — so, no surprise, they’re not an NBFC in disguise.

However, competition isn’t just from Indian peers — imports from global players like Huntsman and BASF keep prices volatile. DCL’s unique edge is being India’s only local producer of ethylene amines, but even monopolies can’t save you if costs explode and demand implodes.

Oh, and they recently added a Trading Division — because when manufacturing stops making money, it’s time to buy and sell someone else’s chemicals instead.

4. Financials Overview

Let’s put on our lab coats and analyze the Q2 FY26 results like forensic accountants with caffeine addictions.

Commentary:
The top line looks like it got dissolved in acid — sales fell more